A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
NCT ID: NCT06664502
The EYE-TIE-201 clinical trial is testing a new drug called EYE201 to see how safe and effective it is for treating certain eye conditions, including diabetic macular edema (DME), neovascular age-r...
Recruiting
Phase: PHASE1
Type: interventional
Locations: Bloomfield, New Jersey, United States, Sacramento, California, United States +25 more